The tourism dynamics in the town are many,” Morris said. “There is no silver bullet. You’re not going to come and pass one or two ordinances and say, ‘job done, ...
Hunter syndrome (MPS II) presentations will include analysis from continued follow-up of Phase 1/2 data for tividenofusp alfa (DNL310), currently under FDA Priority Review Preliminary data from Phase ...
Presenter: Nicole Muschol, M.D., International Center for Lysosomal Disorders (ICLD) at the University Medical Center Hamburg-Eppendorf in Germany Authors: Nicole ...
Following the presentations, the data presented will be available on the Publications page, located within the Pipeline section, of the Company's website at . ULTIMATE I & II are two randomized, ...
A presentation about the many different types of fraud that can impact college students was given in Lumpkin Hall on Oct 21. Jason Donnelly, the vice president and treasury management relationship ...
Presentations to highlight JADE101’s preclinical safety profile and translational framework guiding its clinical development in IgA nephropathy JADE101 is an investigational, potentially best-in-class ...
Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed ...
High-impact datasets across heart, kidney and lung at WTC follows two major publications in the American Journal of Transplantation in the last three months “We are proud to share 16 presentations ...
High-impact datasets across heart, kidney and lung at WTC follows two major publications in the American Journal of Transplantation in the last three months AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results